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Abstract
Background: The genetics of fetal insulin release and/or action have been suggested to affect fetal growth, adult
insulin resistance and adult body composition. The genetic correlation between body composition at birth versus
glycaemic regulation and body composition in adulthood have, however, not been well studied. We therefore
aimed to investigate these genetic correlations in a family-based cohort.
Methods: A Danish family cohort of 434 individuals underwent an oral glucose tolerance test with subsequent
calculation of surrogate measures of serum insulin response and insulin sensitivity. Measures of fetal growth were
retrieved from midwife journals. Heritability and genetic correlations were estimated using a variance component
model.
Results: A high heritability of 0.80 was found for birth weight, whereas ponderal index had a heritability of 0.46.
Adult insulin sensitivity measured as Matsuda index was genetically correlated with both birth weight and ponderal
index (ρG = 0.36 (95% CI: 0.03; 0.69) and ρG = 0.52 (95% CI, 0.15; 0.89), respectively). Only birth weight showed a
significant genetic correlation with adult weight (ρG = 0.38 (95% CI: 0.09; 0.67)) whereas only ponderal index was
genetically inversely correlated with fasting insulin (ρG = - 0.47 (95% CI: - 0.86; - 0.08) and area under the curve for
insulin release during the oral glucose tolerance test (ρG = - 0.66 (95% CI: - 1.13; - 0.19)).
Individual as well as combined adjustment for 45 selected birth weight, obesity and type 2 diabetes susceptibility gene
variants did not affect the correlations.
Conclusions: The genetics of both birth weight and ponderal index appear to be under the same genetic influence as
adult insulin resistance. Furthermore, ponderal index and adult insulin release seem to be partly shared, as well as the
genetics of birth weight and adult weight.
Word count abstract: 281.
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Introduction
Low birth weight associates with adult insulin resistance,
hypertension, coronary-artery disease and type 2 dia-
betes mellitus (T2DM) [1, 2], possibly due to maternal
malnutrition [3, 4] or an insulin-resistant/-deficient
genotype of the foetus [5]. The latter hypothesis, known
as the fetal insulin hypothesis, suggests that genetically
induced insulin resistance or altered insulin secretion
causes impaired insulin-mediated growth in the foetus
and insulin resistance/insulin deficiency in adult life [5].
Birth weight has also been found to display a positive
phenotypical correlation with measures of adult body
mass index (BMI) [6–8]. Although environmental fac-
tors, such as intrauterine conditions, have been shown
to influence this correlation [8], it has also been hypoth-
esized that the genetic background of birth weight and
adult BMI may be partly overlapping [9, 10]. Yet, the ~
100 obesity susceptibility loci identified so far [11] ap-
pear to have a limited influence on birth weight [12, 13],
despite the identification of genetic correlations between
birth weight and traits related to adult obesity, including
BMI, waist and waist-hip ratio using linkage disequilib-
rium (LD) score regression [14]. Out of 60 genetic loci
associating with birth weight in a genome-wide associ-
ation study (GWAS) meta-analysis among European in-
dividuals (n = 153,781) [14], several, including ADCY5,
CDKAL1, HHEX-IDE and ANK1, are also known to as-
sociate with diabetes [14–17], confirming the shared
genetics between birth weight and glucose regulation. In
the same study, the link between birth weight and
T2DM was further demonstrated when using LD score
regression, as birth weight was inversely genetically cor-
related with T2DM [14]. LD score regression is, however,
based on summary statistics from previous GWAS, and
the effect of rare genetic variation is not considered.
Neither do these large-scale studies include detailed phe-
notypes related to adult glycaemic regulation and body
composition.
The primary aim of the current study was therefore to
assess the degree of genetic correlations between fetal
body composition and measures of insulin sensitivity in a
Danish family population with detailed phenotypes using
a variance component model, thereby considering the ef-
fect of both common and rare genetic variation. Secondly,
we aimed to assess the genetic correlations between fetal
body composition and measures of adult body compos-
ition, and finally, the genetic correlation between fetal
body composition and adult levels of insulin secretion. For
significant genetic correlations, we aimed to examine
whether single nucleotide polymorphisms (SNPs) known
to associate with birth weight, adult risk of obesity or adult
risk of T2DM may explain any shared genetics between
the investigated traits. However, as the presence of a sig-
nificant genetic heritability of included traits is a
prerequisite for genetic correlation analysis, heritability es-
timates were made for all included traits.
Methods
Participants
The study population consisted of 533 individuals from
93 Danish families recruited between July 1993 and
April 1999. In each family, one parent was suffering
from verified T2DM according to World Health
Organization 1999 criteria [18], while the other parent
had no known form of diabetes. Patients were recruited
through the outpatient clinic at Steno Diabetes Center
(Gentofte, Denmark) or through a family study per-
formed at the University of Copenhagen (Copenhagen,
Denmark). At diagnosis, probands (n = 93) were ≥ 40
years of age and had no known family history of type 1
diabetes. All family members, i.e. spouses, offspring, and
other relatives, were invited to participate and had an
oral glucose tolerance test (OGTT) performed. In the
current study, only individuals from families with clinical
information on a trio or more family members were in-
cluded (n = 434). These individuals came from 62 fam-
ilies, each comprising 3–12 individuals. In total, 31
individuals receiving diabetes treatment were removed
from analyses involving measures of glucose metabolism.
Clinical examination
Fetal growth measures were retrieved from midwife’s
journals in the local Danish Provincial Archive, and pon-
deral index was calculated as weight (kg)/length (m)3.
When calculating measures of adult body composition
and insulin secretion and sensitivity, individuals as
young as 14 years were included. Although these mea-
sures therefore include information obtained from
youths, the far majority of examined individuals were
adults (≥ 18 years of age). For this reason, as well as for
simplicity, these measures will be termed adult measures
in the following. Adult height, weight, waist and hip cir-
cumference were measured while wearing light indoor
clothes and no shoes. BMI was calculated as weight in
kilos divided by the height in meters squared (kg/m2),
while waist-hip ratio was calculated as waist circumfer-
ence (cm)/hip circumference (cm). Body fat mass and fat
free mass were determined by bioelectrical impedance
[19]. Venous blood samples were drawn after a 12-h
overnight fast with measurements of serum insulin and
blood glucose. In individuals without known T2DM, a
standardized OGTT defined by the World Health
Organization was performed with 15 time points from t
= 0 to t = 240min. Details of the biochemical analyses of
glucose and insulin concentrations have been described
previously [20]. Clinical characteristics of the study
population are provided in Table 1, and an overview of
the family relations is provided in Table 2.
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Variants known to associate with birth weight, BMI and
T2DM
Genotyping was performed using either the MetaboChip
[21] or the Illumina HumanCoreExome Beadchip. Both
types of genotyping were done on an Illumina HiScan
(Illumina, San Diego, CA, USA), and the Genotyping
module (version 1.9.4) of GenomeStudio software (version
2011.1, Illumina) was used to call MetaboChip-derived ge-
notypes. Quality control of HumanCoreExome genotypes
was performed using Illumina GenCall Data Analysis
Software.
Fifteen SNPs or proxies (r2 > 0.90, D’ = 1.000) known
to exert the largest effect on birth weight, adult BMI and
T2DM risk among Caucasians were selected based on
availability (Additional file 1).
Table 1 Phenotypic characterization of the study population
Family relation Probands
(n = 58)
Offspring
(n = 249)
Other relatives
(n = 79)
Spouses
(n = 48)
Trait Mean (SD) Range Mean (SD) Range Mean (SD) Range Mean (SD) Range
Body composition at birth
Sex (men/women) 34/24 NA 118/131 NA 38/41 NA 12/36 NA
Birth weight (g) 3495 (510.9) 2200, 4000 3573 (582.1) 1950, 5500 3622 (467.3) 2300, 4400 3466 (491.8) 1950, 4500
Birth length (cm) 50.8 (2.2) 46.0, 54.0 52.3 (2.2) 45.0, 59.0 52.3 (2.3) 47.0, 59.0 50.7 (2.4) 42.0, 54.0
Ponderal index 26.5 (3.6) 21.3, 36.2 24.9 (2.8) 12.7, 33.6 25.4 (3.1) 19.1, 36.2 26.6 (2.7) 21.3, 32.0
Body composition in adulthood
Age (years) 67.8 (8.2) 43.3, 86.1 40.6 (9.0) 14.9, 73.0 48.9 (16.9) 19.7, 83.6 66.1 (8.2) 42.5, 88.2
Weight (kg) 88.2 (17.7) 56.5, 153.0 78.6 (16.2) 47.5, 134.2 80.3 (16.9) 48.0, 124.0 78.0 (12.5) 57.3, 110.0
Height (cm) 169.0 (10.7) 151.0, 191.5 173.1 (8.6) 154.0, 200.0 169.8 (9.3) 147.0, 192.0 165 (6.9) 152.0, 179.0
Waist (cm) 101.1 (14.1) 79.0, 150.0 86.3 (13.9) 61.0, 128.0 90.9 (14.4) 63.0, 126.0 92.0 (11.4) 72.0, 118.0
Hip (cm) 105.9 (10.5) 91.0, 155.0 99.6 (8.89) 76.0, 132.0 101.9 (11.4) 81.0, 137.0 104.1 (9.8) 87.0, 131.0
Waist-hip ratio 0.95 (0.1) 0.79, 1.19 0.87 (0.10) 0.67, 1.17 0.89 (0.1) 0.68, 1.10 0.88 (0.08) 0.71, 1.09
BMI (kg/m2) 30.8 (5.3) 22.3, 48.8 26.2 (4.85) 16.9, 43.1 27.8 (5.3) 17.9, 43.4 28.8 (5.2) 20.3, 40.8
Fat free mass (kg) 56.5 (13.0) 36.3, 84.2 52.2 (10.8) 30.3, 86.0 53.7 (12.6) 35.8, 85.6 46.5 (7.6) 32.8, 66.6
Fat mass (kg) 32.6 (11.2) 14.2, 79.5 25.6 (11.1) 3.76, 58.8 30.4 (11.6) 5.91, 60.6 30.2 (11.3) 12.0, 58.2
Glyceamic regulation in adulthood
Probands
(n = 28)
Offspring
(n = 246)
Other relatives
(n = 77)
Spouses
(n = 47)
Fasting serum insulin (pmol/l) 66.7 (37.3) 18.0, 160.0 43.0 (31.5) 5.67, 210.3 55.1 (40.4) 15.7, 253.0 52.2 (41.7) 18.3, 267.3
HOMA-B (%) 388.7 (315.8) 58.5, 1090 520.6 (361.5) 75.0, 3182 530.2 (306.9) 73.6, 1853 590.5 (444.5) 170.7, 2839
BIGTT-AIR 998.0 (874.6) 140.9, 1889 2608.0 (1364) 82.7, 9238 2705 (2032) 1261, 14,000 4593 (10884) 1244, 66,560
Insulinogenic index 26.49 (25.2) 7.20, 63.5 134.3 (422.2) 8.35, 5970 101.8 (117.8) 4.91, 815.2 95.5 (75.0) 15.3, 368.3
AUC insulin 4 h (pmol/l*min) 36,600
(30016)
14,350,
77,980
45,380
(32892)
12,120,
223,400
54,370
(30367)
8060,
125,800
68,500
(56029)
21,790,
329,300
Insulin sensitivity
HOMA-IR 22.2 (14.7) 4.98, 57.9 10.8 (9.47) 0.95, 57.5 15.9 (20.1) 3.52, 156.3 13.1 (11.1) 3.90, 64.0
Matsuda insulin sensitivity
index
10.5 (7.3) 2.35, 26.3 10.5 (6.08) 1.50, 38.3 8.81 (5.6) 1.10, 24.7 9.26 (7.43) 0.96, 39.0
Data is presented as means, SD and range for the four different types of family relation (probands, offspring, other relatives and spouses). AUC: area under the
curve, BIGTT-AIR: index for acute insulin response, HOMA-B: HOMA for beta cell function, HOMA-IR: HOMA for insulin resistance
Table 2 Relationships of relative pairs included in analysis
Relationship n
Parent-offspring 173
Siblings 387
Avuncular 82
Half-siblings 16
Third-degree 83
Fourth-degree 56
Unrelated 36
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Individuals and SNPs with a low call rate (< 99%) were
excluded from our analyses. In addition, individuals were
excluded, if their calculated kinship matrix (as based on ge-
notypes) did not correspond to their questionnaire infor-
mation. This was assessed using an Identical-By-Descent
plot in Plink [22].
Calculation of surrogate measures of insulin sensitivity
and insulin release
Based on the OGTT, we calculated surrogate measures
of pancreatic beta-cell insulin secretion (HOMA-index
for pancreatic beta cell function (HOMA-B), the index
for acute serum insulin response based on the OGTT
(BIGTT-AIR), the insulinogenic index, and the area
under the curve (AUC) for insulin) as well as surrogate
measures of insulin resistance (HOMA-index for insulin
resistance (HOMA-IR) and insulin sensitivity (Matsuda
insulin sensitivity index). HOMA-IR is based on mea-
sures in the fasted state in contrast to Matsuda insulin
sensitivity index, which includes insulin sensitivity in the
glucose-stimulated state. AUC for serum insulin was cal-
culated using the trapezoid method, and calculations of
the remaining indices can be found in Additional file 2.
Statistical analyses
Heritabilities and genetic correlations were calculated
using a variance component model in SOLAR software
package, version 4.2.0 [23, 24]. All analyses were ad-
justed for sex. Heritability estimates were calculated
using the ACE model, which estimates the genetic effect
(A), the unique environment effect (E) as well as the
common environmental effect, i.e. the household effect
(C). In the current study, the common shared environ-
ment (C) was defined by households. These effects are
expressed as estimated percentages of the total pheno-
typic variance (P) of a given trait and are termed h2 (the
additive genetic effect), c2 (the effect of the shared envir-
onment) and e2 (the effect of the unique environment).
The heritability of fasting insulin has previously been re-
ported in our study population [20, 25].
Phenotypic and genetic correlations were measured as
Pearson’s phenotypic correlation coefficient (ρP) and Pear-
son’s genetic correlation coefficient (ρG), respectively. Cal-
culations were performed using SOLAR which tests
whether Pearson’s phenotypic correlation coefficient is sig-
nificantly different from 0, and whether Pearson’s genetic
correlation coefficient is significantly different from 0 or 1.
All genetic correlations performed on adult phenotypes
were estimated using adult age-adjusted traits. Further-
more, correlations involving traits related to glycaemic
control were performed using BMI-adjusted glycaemic
traits. In case of non-normally distributed traits or resid-
uals, an inverse normal transformation was applied, as the
kurtosis would otherwise be too high.
As a means to assess the genetic overlap between fetal
and adult traits ascribed to selected high effect-sized
SNPs known to associate with birth weight, adult risk of
obesity or adult risk of T2DM, these SNPs were included
in the bivariate SOLAR model both as individual covari-
ates and as a combined list of covariates.
Heritability analyses did not undergo correction for
multiple testing and neither did analyses based on our
primary hypothesis of a genetic correlation between fetal
body composition and surrogate measures of adult insu-
lin sensitivity. Thus, for these analyses a p-value < 0.05
was considered statistically significant. However, investi-
gation of our secondary hypothesis of the genetic corre-
lations between fetal body composition and measures of
body composition and insulin secretion in adulthood
was corrected for multiple testing. Traits estimating in-
sulin secretion (HOMA-B, BIGTT-AIR, insulinogenic
index and AUC insulin 4 h) are highly correlated, as they
are estimated from the same input data. This is also the
case for measurements of adult body composition
(weight, height, waist, waist-to-hip ratio, BMI and fat
mass). Thus, a p-value < 0.025 (0.05/2) was considered
statistically significant for genetic correlations between
fetal body composition and adult body composition as
well as between fetal body composition and adult insulin
secretion as we are correcting for these two overall
physiological traits (adult body composition and insulin
secretion).
Results
Estimates of heritability
A high genetic heritability of 0.80 (95% CI: 0.37; 1.23)
was found for birth weight, whereas ponderal index had
a heritability of 0.46 (95% CI: 0.01; 0.91). Upon adjust-
ment for shared environment, the genetic heritability for
birth length was non-significant (Table 3).
In adults, the heritability of body composition ranged
from 0.28–0.50, with waist circumference and body fat
mass showing the lowest and highest, respectively (Table
3). When adjusting for shared environment, the herit-
ability of fat free mass was non-significant. Measures of
insulin secretion and sensitivity had heritability estimates
between 0.25 and 0.37 (Table 3).
Genetic correlations between birth weight and insulin
sensitivity
Subsequently, genetic correlations between traits having
a significant genetic heritability were calculated, and we
observed a high genetic correlation between birth weight
and ponderal index (ρG = 0.88 (95% CI: 0.76; 1.00), p =
3.0*10− 10). Yet it was still significantly different from 1
(p = 0.007). We therefore continued with separate gen-
etic correlations for birth weight and ponderal index, as
the genetics of these traits are not identical.
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When we proceeded to assess the genetic correlations
between birth weight and ponderal index and insulin sen-
sitivity, both birth weight and ponderal index showed
significant positive genetic correlations with the OGTT-
derived Matsuda insulin sensitivity index (ρG= 0.36 (95%
CI: 0.03; 0.69), p = 0.047), (ρG= 0.52 (95% CI: 0.15; 0.89),
p = 0.02), respectively (Table 4).
Genetic correlations between birth weight and insulin
secretion
Ponderal index showed an inverse genetic correlation
with AUC for insulin (ρG= − 0.66 (95% CI: -1.13; -0.19),
p = 0.01) (Table 5), however, this correlation was not
significantly different from 1 (p > 0.05). Ponderal index
also showed an inverse genetic correlation with fasting
insulin (ρG = − 0.47 (95% CI: -0.86; − 0.08), p = 0.029),
yet, this correlation did not withstand correction for
multiple testing.
Genetic correlations between birth weight and adult
body weight
When assessing measures of body composition at birth
and in adulthood (Table 6), a significant correlation be-
tween birth weight and adult weight was observed (ρG
= 0.38 (95% CI: 0.09; 0.67), p = 0.02) (Table 6). Unfortu-
nately, information on gestational age was unavailable,
Table 3 Heritability estimates
Body composition measured at birth
Trait n h2 (95% CI) c2 (95% CI) e2 (95% CI)
Birth weight (g) 297 0.80 (0.37; 1.23)* 0.05 (−0.20; 0.30) 0.15 (−0.09; 0.39)
Ponderal index 296 0.46 (0.01; 0.91)* 0.02 (− 0.18; 0.22) 0.53 (0.22; 0.84)*
Birth length (cm) 296 0.15 (−0.54; 0.84) 0.17 (−0.18; 0.52) 0.67 (0.30; 1.04)*
Adult body composition
Weight (kg) 406 0.35 (0.04; 0.66)* 0.01 (−0.15; 0.17) 0.64 (0.42; 0.86)*
Height (cm) 406 0.30 (0.01; 0.59)* 0.32 (0.12; 0.52)* 0.39 (0.21; 0.57)*
Waist (cm) 398 0.28 (−0.01; 0.57)* 0.03 (−0.13; 0.19) 0.69 (0.49; 0.89)*
Waist-hip ratio 397 0.34 (0.14; 0.54)* 0 (0) 0.66 (0.46; 0.86)*
BMI (kg/m2) 406 0.32 (0.03; 0.61)* 0.07 (−0.07; 0.21) 0.61 (0.39; 0.83)*
Fat mass (kg) 338 0.50 (0.26; 0.74)* 0 (0) 0.50 (0.26; 0.74)*
Fat free mass (kg) 338 0.09 (−0.52; 0.70) 0.17 (−0.16; 0.50) 0.74 (0.39; 1.09)*
Adult measures of glycaemic control
Insulin secretion
HOMA-B (%) 367 0.27 (−0.06; 0.60)* 0.02 (−0.16; 0.20) 0.71 (0.38; 1.04)*
BIGTT-AIR 312 0.31 (0.09; 0.53)* 0 (0) 0.69 (0.47; 0.91)*
Insulinogenic index 318 0.25 (0.03; 0.47)* 0 (0) 0.75 (0.53; 0.97)*
AUC insulin 4 h (pmol/l*min) 302 0.25 (1.01; 0.49)* 0 (0) 0.75 (0.51; 0.99)*
Insulin sensitivity
HOMA-IR 367 0.37 (0.12; 0.62)* 0 (0) 0.63 (0.38; 0.88)*
Matsuda insulin sensitivity index 367 0.31 (0.07; 0.55)* 0 (0) 0.69 (0.45; 0.93)*
Heritabillity estimates were calculated using the ACE model. All heritability estimates were adjusted for sex, and heritability estimates of adult measures were
additionally adjusted for age
BIGTT-AIR: index for acute insulin response, c2 = common environmental effect, e2 = unique environmental effect, h2 = additive genetic effect. *Heritability estimate
significantly different from zero (p < 0.05)
Table 4 Correlations between measures of birth body composition and adult measures of insulin sensitivity
Birth weight (g) Ponderal index
n ρP ρG (95% CI) n ρP ρG (95% CI)
Insulin sensitivity in adulthood
HOMA-IR 376 - 0.12 - 0.31 (- 0.64; 0.02) 376 - 0.09 - 0.35 (- 0,76; 0.06)
Matsuda insulin sensitivity index 376 0.15* 0.36 (0.03; 0.69)*# 376 0.14* 0.52 (0.15; 0.89)*#
Phenotypic correlations between traits were estimated as ρP, and genetic correlations were estimated as ρG (95% CI). Correlations were estimated in non-diabetic
relatives of patients with type 2 diabetes mellitus. All correlations were adjusted for sex. *Correlation significantly different from zero (p < 0.05). #Correlation remained
significant following adjustment for both birth weight and adult type 2 diabetes susceptibility SNPs. All genetic correlations were significantly different from 1 (p < 0.05)
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so we performed a sensitivity analysis by only including
individuals having a birth weight > 2500 g, thereby likely
excluding individuals born premature. This did, however,
not affect our findings, as we found a significant genetic
correlation between birth weight and adult weight (ρG=
0.42 (95% CI: 0.13; 0.71), p = 0.01).
Genetic associations
To estimate the genetic overlap ascribed to variants
known to influence the analysed trait, the statistically
significant genetic correlations between birth weight
and adult glycaemic regulation were adjusted for birth
weight and T2DM susceptibility SNPs (Additional file
1). Likewise, significant genetic correlations between
birth weight and adult body weight were adjusted for
high effect-sized birth weight and BMI susceptibility
SNPs. Following this adjustment, all significant gen-
etic correlations remained unaffected (Table 4, Table
5 and Table 6).
Discussion
Birth weight is highly heritable
The highest heritability for body-composition at birth
was observed for birth weight (0.80). The heritability of
birth weight has in twin studies previously been found
to be between 0.15–0.40 [26–28], however, such studies
may be affected by competition for nutrients in the pla-
centa. In contrast, a large study of offspring of
twin-pairs (n > 5000) found a heritability of birth weight
of 0.70 [29], and a heritability of 0.92 has been reported
in a Hispanic family-based study [30]. To date, only one
previous study, comprising 917 individuals, has investi-
gated the heritability of ponderal index which was found
to be 0.39. The same study also reported the herit-
ability for birth weight to be 0.67 [31]. In studies of
twins and singletons, the heritability of birth length
has previously been reported to be 0.27 and 0.26, re-
spectively [32]. However, in the current study, the
genetic heritability for birth length was not signifi-
cantly different from 0. Potentially, this could be due
to the low statistical power in our study or due to
the fact that shared environmental effect was taken
into account.
Choh and colleagues also tested whether the genetics
involved in ponderal index are overlapping with the gen-
etics of birth weight, and the genetic correlation between
these traits were 0.30 (SE: 0.12) [31]. In the present
study, the genetic overlap between birth weight and pon-
deral index was 0.88, yet, still significantly different from
1. Thus, birth weight and ponderal index are, at least in
part, genetically distinct.
Table 5 Correlations between measures of birth body composition and adult measures of insulin secretion
Birth weight (g) Ponderal index
n ρP ρG (95% CI) n ρP ρG (95% CI)
Insulin secretion in adulthood
HOMA-B (%) 376 - 0.01 - 0.22 (- 0.57; 0.13) 376 - 0.08 - 0.33 (- 0.76; 0.10)
BIGTT-AIR 349 0.11 - 0.03 (- 0.44; 0.38) 349 0.03 - 0.10 (- 0.61; 0.41)
Insulinogenic index 348 0.06 0.08 (- 0.31; 0.47) 348 - 0.02 - 0.18 (- 0.67; 0.31)
AUC insulin 4 h (pmol/l*min) 345 - 0.14* - 0.29 (- 0.72; 0.14) 345 - 0.14* - 0.66 (- 1.13; - 0.19)*#
Fasting serum insulin (pmol/l) 377 - 0.09 - 0.28 (- 0.61; 0.05) 377 - 0.13* - 0.47 (- 0.86;− 0.08)*#
Phenotypic correlations between traits were estimated as ρP, and genetic correlations were estimated as ρG (95% CI). Correlations were estimated in non-diabetic
relatives of patients with type 2 diabetes mellitus. All correlations were adjusted for sex. *Correlation significantly different from zero (p < 0.05). #Correlation remained
significant following adjustment for both birth weight and adult type 2 diabetes susceptibility SNPs
AUC: area under the curve, BIGTT-AIR: index for acute insulin response, HOMA-B: HOMA for beta cell function
Table 6 Phenotypic and genetic correlations between measures of body composition at birth and in adulthood
Birth weight (g) Ponderal index
Traits measured in adulthood n ρP ρG (95% CI) n ρP ρG (95% CI)
Weight (kg) 411 0.25* 0.38 (0.09; 0.67)*# 411 0.15 0.12 (- 0.31; 0.55)
Height (cm) 411 0.16* 0.17 (- 0.14; 0.48) 411 - 0.08 0.33 (- 0.02; 0.68)
Waist (cm) 406 0.08 0.08 (- 0.27; 0.43) 406 0.08 - 0.24 (- 0.65; 0.17)
Waist-hip ratio 406 - 0.03 0.03 (- 0.32; 0.38) 406 - 0.01 - 0.36 (- 0.75; 0.03)
BMI (kg/m2) 411 0.16* 0.24 (- 0.07; 0.55) 411 0.12 - 0.01 (- 0.42; 0.40)
Fat mass (kg) 376 0.04 0.04 (- 0.29; 0.37) 376 0.01 - 0.06 (- 0.47; 0.35)
Phenotypic correlations between traits were estimated as ρP (95% CI), and genetic correlations were estimated as ρG (95% CI). All correlations were adjusted for
sex. *Correlation significantly different from zero (p < 0.05). #Correlation remained significant following adjustment for both birth weight and adult BMI
susceptibility SNPs. All genetic correlations were significantly different from 1 (p < 0.05)
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Birth weight and insulin secretion/sensitivity in adulthood
have overlapping genetic pathways
Our primary aim was to investigate the genetic overlap
between fetal body composition and measures of adult
insulin sensitivity. We found a positive correlation both
between birth weight and ponderal index and Matsuda
index of insulin sensitivity. These correlations indicate,
that genetic variation having a diminishing effect on fetal
body composition also decrease insulin sensitivity in
support of the fetal insulin hypothesis, suggesting that a
genetic disposition to insulin resistance is affecting not
only adult metabolism but also fetal growth. Although
not statistically significant, both birth weight and pon-
deral index displayed negative directionally genetic cor-
relations with HOMA-IR, further supporting the fetal
insulin hypothesis.
When assessing the genetic correlations between fetal
body composition and measures of insulin secretion, we
observe negative correlations between ponderal index
and insulin secretion. This is implying that a low pon-
deral index is linked to an increased insulin secretion in
adulthood, which could be a compensatory mechanism
in response to insulin resistance, thus, it is also in ac-
cordance with the fetal insulin hypothesis. This genetic
correlation was not observed between birth weight and
indices of insulin secretion. With insulin being an im-
portant intra-uterine growth factor, a reduction in pon-
deral index due to an increased birth length may be a
result of higher levels of fetal insulin.
Birth weight and adult weight share genetic pathways
A positive genetic correlation was also found between
birth weight and adult weight, yet, no significant genetic
correlation was found between birth weight and adult fat
mass. Thus, we speculate that the genetic overlap be-
tween birth weight and adult weight may be mediated
through regulation of lean body mass. Body composition
differentiates between men and women, and although
our analyses were adjusted for sex, sex-specific genetic
correlations between birth weight and adult measures of
body composition would have been desirable. Unfortu-
nately, our study sample did not allow us to perform
sex-specific analyses, and larger studies are required to
further investigate this hypothesis.
Cross-trait LD score regression has been used to esti-
mate genetic overlap between several traits [14, 33].
Using this approach, Bulik-Sullivan et al. analysed data
from 24 GWASs comprising > 1,5 million individuals,
and although no significant genetic correlations between
birth weight and overweight or obesity were found, the
authors identified a positive genetic correlation between
birth weight and adult waist circumference (ρG= 0.14
(SE: 0.06)) [33]. A succeeding study combining data
from 37 GWAS and encompassing up to 153,781
individuals also identified a genetic correlation between
birth weight and adult BMI (ρG= 0.11 (SE: 0.03)) [14].
However, traits differentiating between lean and fat body
mass were not investigated in either studies, nor was the
effect of rare genetic variation accounted for as these
studies were based on GWAS data.
In the current study, individual or combined adjust-
ment for SNPs with a known substantial effect size on
either birth weight, BMI or T2DM did not alter the gen-
etic correlations. Thus, none of the 45 included SNPs
therefore significantly influcences the identified genetic
correlations between body composition at birth and
adult measures of insulin secretion and sensitivity or be-
tween body composition at birth and in adulthood. The
lack of effect of BMI SNPs on both fetal and adult body
composition maybe not be surprising considering that it
has previously been established that GWAS-identified
BMI loci only affect BMI at certain life stages [34]. Inter-
estingly, Horikoshi and colleagues estimated that 0.39
(95% CI: 0.17–0.61) of the co-variance between birth
weight and adult BMI could be explained by the >
300,000 SNPs directly genotyped in their study [14], fur-
ther demonstrating that the shared genetics between
birth weight and adult BMI can be attributed to the ef-
fect of a vast number of common genetic variations ra-
ther than to a few high effect sized variants.
Finally, it should be noted that all the genetic correla-
tions should be considered relative to the genetic herit-
ability of the examined traits, thus, a large genetic
correlation in the light of low heritability indicates, that
only a minor proportion of the phenotypic variation is
explained by overlapping genetics.
The present study is limited by the relatively small
sample size, which reduces our statistical power. We can
therefore not exclude the possibility that non-significant
genetic correlations are a result of type 2 statistical er-
rors. Furthermore, although the measurements of fetal
body composition were obtained by trained professional
staff, especially measurements of birth length are known
to be prone for measuring error. As ponderal index is a
function of birth weight and birth length, potential
measuring errors may affect our findings and could ex-
plain some of the observed differences between the re-
sults obtained for birth weight and ponderal index. In
addition, the family design may inflate our measures of
heritability as compared to the more recent approach of
estimating heritability by genotyping common genetic
variants in large population-based populations. Although
such an approach is statistically powerful, it does not
include the effect of variants not captured by such
genotyping, including rare variants. Due to the large
samples often employed in such analysis, this approach
does not enable the inclusion of detailed phenotypes,
e.g. OGTT-derived measures. This in in contrast to our
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family-based study, which includes detailed phenotypes
related to body composition, insulin secretion and insu-
lin sensitivity in adulthood and takes both common and
rare forms of genetic variation as well as shared environ-
ment into account.
Conclusions
Among Danes of Caucasian ethnicity, the genetics of
birth weight and ponderal index appear to be partly
shared with the genetics of adult insulin resistance, sup-
porting the fetal insulin hypothesis. Yet, only ponderal
index shared genetic regulation with adult insulin release
and only birth weight shared with adult weight. These
genetic correlations could not be explained by variants
known to influence any of the above-mentioned traits.
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